Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127438721 | 12743872 | 1 | I | 20140828 | 20160901 | 20160914 | 20160914 | EXP | JP-MALLINCKRODT-T201604283 | MALLINCKRODT | 71.00 | YR | M | Y | 0.00000 | 20160914 | CN | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127438721 | 12743872 | 1 | PS | METHADONE | METHADONE HYDROCHLORIDE | 1 | Oral | 10 MG (30 MG DAILY DOSE) | UNKNOWN | 40517 | TABLET | ||||||||
| 127438721 | 12743872 | 2 | SS | METHADONE | METHADONE HYDROCHLORIDE | 1 | Oral | 15 MG (45 MG DAILY DOSE) | UNKNOWN | 40517 | TABLET | ||||||||
| 127438721 | 12743872 | 3 | SS | METHADONE | METHADONE HYDROCHLORIDE | 1 | Oral | 5 MG (15 MG DAILY DOSE) | UNKNOWN | 40517 | TABLET | ||||||||
| 127438721 | 12743872 | 4 | SS | METHADONE | METHADONE HYDROCHLORIDE | 1 | Oral | 10 MG (30 MG DAILY DOSE) | UNKNOWN | 40517 | TABLET | ||||||||
| 127438721 | 12743872 | 5 | C | MORPHINE HYDROCHLORIDE HYDRATE | MORPHINE HYDROCHLORIDE | 1 | Parenteral | 192 MG | 0 | ||||||||||
| 127438721 | 12743872 | 6 | C | MORPHINE HYDROCHLORIDE HYDRATE | MORPHINE HYDROCHLORIDE | 1 | Parenteral | 6-8 MG, PRN | 0 | ||||||||||
| 127438721 | 12743872 | 7 | C | TAKEPRON | LANSOPRAZOLE | 1 | Oral | 15 MG | 0 | ||||||||||
| 127438721 | 12743872 | 8 | C | MUCOSOLVAN | AMBROXOL HYDROCHLORIDE | 1 | Oral | 45 MG | 0 | ||||||||||
| 127438721 | 12743872 | 9 | C | MUCODYNE | CARBOCYSTEINE | 1 | Oral | 1500 MG | 0 | ||||||||||
| 127438721 | 12743872 | 10 | C | LOXONIN | LOXOPROFEN SODIUM | 1 | Oral | 120 MG | 0 | ||||||||||
| 127438721 | 12743872 | 11 | C | MUCOSTA | REBAMIPIDE | 1 | Oral | 300 MG | 0 | ||||||||||
| 127438721 | 12743872 | 12 | C | ADONA | CARBAZOCHROME SODIUM SULFONATE | 1 | Oral | 90 MG | 0 | ||||||||||
| 127438721 | 12743872 | 13 | C | MAGMITT | MAGNESIUM OXIDE | 1 | Oral | 990 MG | 0 | ||||||||||
| 127438721 | 12743872 | 14 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Oral | 20 MG | 0 | ||||||||||
| 127438721 | 12743872 | 15 | C | TRAMCET | ACETAMINOPHENTRAMADOL | 1 | Oral | 4 DF | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127438721 | 12743872 | 1 | Cancer pain |
| 127438721 | 12743872 | 5 | Analgesic therapy |
| 127438721 | 12743872 | 10 | Analgesic therapy |
| 127438721 | 12743872 | 14 | Analgesic therapy |
| 127438721 | 12743872 | 15 | Analgesic therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127438721 | 12743872 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127438721 | 12743872 | Non-small cell lung cancer | |
| 127438721 | 12743872 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127438721 | 12743872 | 1 | 20140823 | 20140828 | 0 | |
| 127438721 | 12743872 | 2 | 20140829 | 20140902 | 0 | |
| 127438721 | 12743872 | 3 | 20140906 | 20140921 | 0 | |
| 127438721 | 12743872 | 4 | 20140922 | 20150520 | 0 | |
| 127438721 | 12743872 | 5 | 20140725 | 20140829 | 0 | |
| 127438721 | 12743872 | 6 | 20140721 | 0 | ||
| 127438721 | 12743872 | 15 | 20140724 | 20140902 | 0 |